BBH icon

VanEck Biotech ETF

111 hedge funds and large institutions have $152M invested in VanEck Biotech ETF in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less ownership

Funds ownership:

16% less capital invested

Capital invested by funds: $180M → $152M (-$28.5M)

39% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 31

Holders
111
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$9.68M
2 -$9.21M
3 -$5.76M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.73M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$27.4M
2
$17.7M
3
$10.5M
4
$9.27M
5
$8.3M
6
$6.71M
7
$4.63M
8
$4.47M
9
$4.21M
10
$3.86M
11
$3.5M
12
$3.42M
13
$3.13M
14
$3.13M
15
$2.96M
16
$2.21M
17
$1.98M
18
$1.79M
19
$1.53M
20
$1.52M
21
$1.45M
22
$1.32M
23
$1.25M
24
$1.21M
25
$1.19M